Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib

AIM: To evaluate the value of systemic inflammation-based markers as prognostic factors for advanced pancreatic cancer (PC). METHODS: Data from 82 patients who underwent combination chemotherapy with gemcitabine and erlotinib for PC from 2011 to 2014 were collected retrospectively. Data that include...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:World J Gastrointest Oncol
Hoofdauteurs: Lee, Jae Min, Lee, Hong Sik, Hyun, Jong Jin, Choi, Hyuk Soon, Kim, Eun Sun, Keum, Bora, Seo, Yeon Seok, Jeen, Yoon Tae, Chun, Hoon Jai, Um, Soon Ho, Kim, Chang Duck
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Baishideng Publishing Group Inc 2016
Onderwerpen:
Retrospective Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4942744/
https://ncbi.nlm.nih.gov/pubmed/27559435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v8.i7.555
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items